dexamethasone sodium phosphate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
DBL DEXAMETHASONE SODIUM PHOSPHATE INJECTION 8mg/2mL (as sodium) injection vial
AUST R: 178774
Active ingredients:
dexamethasone sodium phosphate

Dosage form:
Injection, solution

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800 675 229

From
04 Jul 2022
to
19 Aug 2022

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in consumer demand

Management action:
Other strengths are available. An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

DEXAMETHASONE MYLAN dexamethasone phosphate (as dexamethasone sodium phosphate) 4mg/1mL solution for injection vial
AUST R: 163200
Active ingredients:
dexamethasone sodium phosphate

Dosage form:
Injection

Sponsor:
Alphapharm Pty Ltd

Phone:
1800 274 276

From
01 Jun 2022
to
27 Oct 2022

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
An unregistered product has been approved for supply under Section 19A. The approval holder, Alphapharm Pty Ltd can be contacted on 1800 274 276 for details on supply

DEXAMETHASONE MYLAN dexamethasone phosphate (as dexamethasone sodium phosphate) 8mg/2mL solution for injection vial
AUST R: 163199
Active ingredients:
dexamethasone sodium phosphate

Dosage form:
Injection

Sponsor:
Alphapharm Pty Ltd

Phone:
1800 274 276

From
06 Jul 2022
to
31 Oct 2022

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
An unregistered product has been approved for supply under Section 19A. The approval holder, Alphapharm Pty Ltd can be contacted on 1800 274 276 for details on supply

DBL DEXAMETHASONE SODIUM PHOSPHATE INJECTION 4mg/1mL (as sodium) injection ampoule
AUST R: 16374
Active ingredients:
dexamethasone sodium phosphate

Dosage form:
Injection, solution

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800 675 229

Deletion from market:
01 Nov 2023

Shortage status:
To be discontinued

Availability:
Unavailable

Reason:
Manufacturing

Management action:
An alternate presentation of the same strength is available.